image
Sonnet BioTherapeutics Holdings, Inc. SONN
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 3.02
0.667 %
$ 2.53 M
Market Cap
-3.15
P/E
BALANCE SHEET
5.43 M ASSETS
-6.87%
Growth Rates
1Year -6.87%
3Years -12.10%
5Years -28.86%
7Years -22.89%
10Years -12.26%
5.66 M LIABILITIES
-32.42%
Growth Rates
1Year -32.42%
3Years 4.37%
5Years -23.46%
7Years -16.22%
10Years -4.38%
-226 K EQUITY
91.10%
Growth Rates
1Year 91.10%
3Years -2.43%
5Years -0.60%
7Years -0.25%
10Years -0.20%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Sonnet BioTherapeutics Holdings, Inc.
image
Current Assets 4.74 M
Cash & Short-Term Investments 2.27 M
Receivables 787 K
Other Current Assets 1.68 M
Non-Current Assets 691 K
Long-Term Investments 0
PP&E 227 K
Other Non-Current Assets 464 K
Current Liabilities 5.52 M
Accounts Payable 2.2 M
Short-Term Debt 73 K
Other Current Liabilities 3.25 M
Non-Current Liabilities 131 K
Long-Term Debt 131 K
Other Non-Current Liabilities 0

Balance Sheet

Millions
Sep-2023 Sep-2022 Sep-2021 Sep-2020 Sep-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007
ASSETS
Cash & Cash Equivalents 2.3 3.1 27.6 7.3 35.7 K 0.5 0.4 0.3 1.5 0 0.4 1.2 0.2 46.0 2.37 K 14.2 K 0
Short Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Receivables 0.8 0 0 0 0 0.3 0.5 0.5 0.9 0 0.4 0.4 0.2 4.3 0 0 18.9 K
Inventory 0 (0.7) 0 0 0.5 0.3 0.5 0.5 0.7 0 0.4 0.2 59.3 K 0 0 0 0
Other Current Assets 1.7 4.0 2.4 0.6 4.1 K 0.5 0.4 0.5 1.2 0 0.5 0.2 0.2 108.5 57.8 K 9.4 K 0
Total Current Assets 4.7 5.4 28.8 7.6 39.8 K 1.3 1.8 1.8 3.8 0 1.7 2.0 0.6 158.7 60.2 K 23.6 K 18.9 K
PP&E 0.2 0.3 0.2 0.3 10.5 9.8 8.5 11.5 16.6 0 5.6 2.3 2.5 25.6 32.1 K 36.2 K 45.5 K
Intangible Assets 0 0 0 0 5.1 15.0 18.5 18.9 7.3 0 3.4 0.6 0.5 0 0 0 0
Goodwill 0 0 0 0 11.3 10.6 12.6 12.4 12.7 0 6.5 0.4 0 0 0 0 0
Long Term Investments 0 0 0 0 0.8 0.8 0.8 0.8 31.3 K 0 55.1 K 56.9 K 0.3 352.5 83.3 K 0.1 0
Other Long Term Assets 0.5 0.1 (0.2) 83 K 0.4 2.9 0.5 0.4 1.7 0 2.8 2.3 1.6 877.8 1.3 2.1 0
Other Assets 0 0 0 0 (28.1) 0 0 0 0 0 0 0 0 0 0 0 3.8
Total Assets 5.4 5.8 29.0 8.0 39.8 K 29.8 30.2 33.5 42.2 0 20.1 7.6 5.5 1 414.6 1.5 2.2 3.8
LIABILITIES
Accounts Payable 2.2 4.8 3.8 2.1 1.8 2.4 3.7 3.8 0 0 2.4 0.7 0.3 211.4 0.2 0.2 25.6 K
Short Term Debt 73 K 52.1 K 95.3 K 0.1 0.2 9.2 8.7 6.4 8.2 0 0.8 0.3 2.8 250.0 0.4 0.5 0.2
Other Current Liabilities 3.2 3.2 2.3 2.1 0.8 4.0 2.4 1.7 7.9 0 2.3 0.8 0.5 182.5 0 0 0
Total Current Liabilities 5.5 8.2 6.7 4.7 2.9 13.0 14.7 12.1 16.2 0 5.5 1.8 3.6 645.6 0.6 0.7 0.3
Long Term Debt 0.1 0.2 30.6 K 0.3 0 3.7 0.7 4.0 1.1 0 0.1 60.5 K 0.2 686.5 0 0 0
Deferred Tax Income 0 0 0 0 76.8 K 76.8 K 0.8 1.5 1.4 0 1.3 0 0 0 0 0 0
Other Liabilities 0 0 0 0 (0.1) 3.6 2.2 2.0 1.8 0 0.8 0.2 0 0 0.1 7.8 K 29.9 K
Total Liabilities 5.7 8.4 6.7 5.0 2.9 21.5 18.7 19.5 20.4 0 8.8 2.1 3.9 1 332.1 0.7 0.7 0.3
EQUITY
Common Stock 175 554 6.02 K 1.47 K 555 373 305 2.14 K 2.13 K 0 541 370 301 0.3 0 0 833
Retained Earnings (110.2) (91.4) (61.7) (36.7) (12.4) (57.1) (49.1) (42.2) (33.0) 0 (14.5) (9.3) (6.0) (4 929.4) (3.9) (2.0) 0
Other Accumulative Comprehensive Income/Loss 0 0 0 0 (0.2) (0.2) (0.9) (1.2) (1.0) 0 0 0 0 0 0 (1.2) 0
Total Equity (0.2) (2.5) 22.3 3.0 (2.0) 8.3 11.5 13.6 22.1 0 11.6 5.6 3.3 106.6 0.7 1.5 3.5
Total Liabilities and Equity 5.4 5.8 29.0 8.0 39.8 K 29.8 30.2 33.5 42.2 0 20.1 7.6 5.5 1 414.6 1.5 2.2 3.8
SHARES OUTSTANDING
Common Shares Outstanding 1.0 0.2 79.7 K 30.6 K 871 440 315 271 285 191 87.3